Aptus Capital Advisors, LLC Ionis Pharmaceuticals Inc Transaction History

Aptus Capital Advisors, LLC

  • $6.27 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 19, 2020
SELL
$47.45 - $62.95 $163,702 - $217,177
-3,450 Closed
0 $0
Q2 2020

Jul 22, 2020
BUY
$46.85 - $61.05 $161,632 - $210,622
3,450 New
3,450 $203,000
Q2 2019

Aug 13, 2019
SELL
$62.09 - $86.14 $159,943 - $221,896
-2,576 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$52.92 - $81.17 $136,321 - $209,093
2,576 New
2,576 $209,000

Others Institutions Holding IONS

# of Institutions
402
Shares Held
136M
Call Options Held
862K
Put Options Held
582K
View Full List

About IONIS PHARMACEUTICALS INC

IONS Quotes by TradingView
  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $4.83B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Aptus Capital Advisors, LLC Portfolio

Follow Aptus Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aptus Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aptus Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email